tiprankstipranks
Novo Nordisk Completes Share Buyback
PremiumCompany AnnouncementsNovo Nordisk Completes Share Buyback
4d ago
Galderma Seizes Ozempic Face Opportunity
PremiumMarket News
Galderma Seizes Ozempic Face Opportunity
4d ago
FTC expands patent listing challenges for drugs
PremiumThe Fly
FTC expands patent listing challenges for drugs
5d ago
Senate to probe Ozempic’s ‘outrageously’ high prices, FT reports
PremiumThe FlySenate to probe Ozempic’s ‘outrageously’ high prices, FT reports
11d ago
Novo Nordisk Launches Massive Share Buyback
PremiumCompany Announcements
Novo Nordisk Launches Massive Share Buyback
13d ago
VGK vs. EZU: Which Is the Better European Stock ETF?
PremiumMarket News
VGK vs. EZU: Which Is the Better European Stock ETF?
15d ago
LLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?
PremiumMarket NewsLLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?
18d ago
Novo Nordisk price target raised to DKK 990 from DKK 930 at Morgan Stanley
PremiumThe Fly
Novo Nordisk price target raised to DKK 990 from DKK 930 at Morgan Stanley
20d ago
LLY, NVO: Obesity Drugs May Help with Parkinson’s
PremiumMarket News
LLY, NVO: Obesity Drugs May Help with Parkinson’s
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100